Swiss-Prot Group, SIB Swiss Institute of Bioinformatics, Switzerland.
Antiviral Res. 2020 May;177:104759. doi: 10.1016/j.antiviral.2020.104759. Epub 2020 Mar 1.
• Integrin may act as an alternative receptor for SARS-CoV-2 and could be implicated in its transmission and pathology. • The spike protein of SARS-CoV-2 acquired a RGD motif known to bind integrins. This motif is absent from other coronaviruses. • The integrin-binding motif is present at the surface of the spike protein, close to the ACE2 receptor-binding region. • Integrin binding may be a promising therapeutics target, and should be tested experimentally.
• 整合素可能作为 SARS-CoV-2 的替代受体,并可能与其传播和发病机制有关。 • SARS-CoV-2 的刺突蛋白获得了一个已知与整合素结合的 RGD 基序。该基序不存在于其他冠状病毒中。 • 整合素结合基序位于刺突蛋白的表面,靠近 ACE2 受体结合区域。 • 整合素结合可能是一个有前途的治疗靶点,应进行实验验证。